Tag: Cancer: Prostate
Predictors ID’d for Switching to Active Tx in Prostate Cancer
Ethnicity influences patient decision to pursue active treatment and serial biopsies in active surveillance
QOL Not Affected by Active Surveillance of Prostate Cancer
Choosing no treatment and regular check-ups didn't seem to stress men with low-risk disease
Similar Outcomes for Robot-Assisted, Radical Prostatectomy
Similar functional outcomes at 12 weeks post-surgery for newly diagnosed localized prostate CA
Metastatic Prostate Cancer Cases Increasing in the United States
Findings highlight continued need for nationwide refinements in prostate cancer screening
MRI Feasible for Predicting Prostate CA in Unselected Sample
Adjusted odds ratio of prostate cancer significantly higher for MRI score than PSA
DNA-Repair Gene Mutations ID’d in Metastatic Prostate Cancer
Prevalence of 11.8 percent for germline DNA-repair gene mutations presumed to be deleterious
Docs Tending Away From Post-Prostatectomy Adjuvant RT
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 versus 2012
Benefits for Robotic-Assisted Laparoscopic Prostatectomy
Reduced risk of positive surgical margins versus open prostatectomy for patients with pT2 disease only
Prostate Cancer Diagnoses Down From 2011 to 2013
Use of active surveillance increasing, active treatment decreasing for low-risk disease
ADT Plus Radiotherapy Ups Survival in Metastatic Prostate CA
Superior median, five-year OS for prostate RT plus ADT versus ADT alone in propensity score analyses
